» Articles » PMID: 20504879

P53 is Balancing Development, Differentiation and De-differentiation to Assure Cancer Prevention

Overview
Journal Carcinogenesis
Specialty Oncology
Date 2010 May 28
PMID 20504879
Citations 91
Authors
Affiliations
Soon will be listed here.
Abstract

Many of the roles played by the tumor suppressor p53 in restraining cancer initiation and progression are well established. These include the ability of p53 to induce cell-cycle arrest, DNA repair, senescence and apoptosis. In addition, during the 30 years of p53 research, numerous studies have implicated p53 in the regulation of differentiation and developmental pathways. Here, we summarize the data on these relatively less-characterized functions of p53, including its involvement in embryogenesis and various differentiation programs, as well as its function in restraining de-differentiation of mature somatic cells. Besides the well-known functions of p53 as a cell-cycle regulator and a mediator of apoptosis, both coincide with differentiation processes, p53 was shown to exert its effects on various differentiation programs via direct regulation of specific key factors controlling these programs. The complex regulation by p53, which acts to suppress or to induce differentiation, is mainly the result of the specific cell type and fate. We argue that regulation of differentiation is pivotal for the tumor-suppressive activity of p53, which act to maintain the proper cellular state, preventing improper maturation or reprogramming. This conclusion is further supporting the notion that aberrant differentiation is associated with malignant transformation.

Citing Articles

Decoding the molecular symphony: interactions between the mA and p53 signaling pathways in cancer.

Shoemaker R, Huang M, Wu Y, Huang C, Lee D NAR Cancer. 2024; 6(3):zcae037.

PMID: 39329012 PMC: 11426327. DOI: 10.1093/narcan/zcae037.


Exploring the Functional Landscape of the p53 Regulatory Domain: The Stabilizing Role of Post-Translational Modifications.

Bakker M, Svensson O, So Rensen H, Skepo M J Chem Theory Comput. 2024; 20(14):5842-5853.

PMID: 38973087 PMC: 11270737. DOI: 10.1021/acs.jctc.4c00570.


Cockayne Syndrome Patient iPSC-Derived Brain Organoids and Neurospheres Show Early Transcriptional Dysregulation of Biological Processes Associated with Brain Development and Metabolism.

Szepanowski L, Wruck W, Kapr J, Rossi A, Fritsche E, Krutmann J Cells. 2024; 13(7.

PMID: 38607030 PMC: 11011893. DOI: 10.3390/cells13070591.


Targeting mutant p53 stabilization for cancer therapy.

Wang J, Liu W, Zhang L, Zhang J Front Pharmacol. 2023; 14:1215995.

PMID: 37502209 PMC: 10369794. DOI: 10.3389/fphar.2023.1215995.


LSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase function.

Kumaraswamy A, Duan Z, Flores D, Zhang C, Sehrawat A, Hu Y JCI Insight. 2023; 8(15).

PMID: 37440313 PMC: 10445684. DOI: 10.1172/jci.insight.167440.